Tiziana Life Sciences Ltd. announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, purchased 18,000 common shares at $0.80 per share.
June 9, 2022
· 1 min read